Vicore Pharma Holding AB (VCRE:NASDAQ) closed at $9.09 on October 15, 2026, up 0.11% on the day. The stock trades 48.9% below its 52-week high of $17.80 and 15.4% above its 52-week low of $7.88. Over the past year, it lost 44.1%. Vicore Pharma Holding AB is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -1.52% | -14.65% | -20.54% | -44.06% | -44.06% |
In 72 trading sessions since July 7, 2026, VCRE closed higher on 26 days (36%). Its best day was August 12, 2026 (+6.55%) and its worst was July 13, 2026 (-8.20%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 1 time.
Vicore Pharma is a clinical-stage biopharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential in respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).
Find more stocks like VCRE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.